LONG-TERM RESULTS OF THE CORRECTION OF METABOLIC RISK IN WOMEN WITH POLYCYSTIC OVARY SYNDROME AFTER METFORMIN MONOTHERAPY AND COMBINATION THERAPY
- Authors: Sheremetyeva E.1, Andreeva E.1, Dedov I.1
-
Affiliations:
- Endocrinology Research Center
- Issue: Vol 23, No 8 (2012)
- Pages: 56-61
- Section: Articles
- URL: https://journals.eco-vector.com/0236-3054/article/view/115474
- ID: 115474
Cite item
Open Access
Access granted
Abstract
The polycystic ovary syndrome (POS) is a polymorphic disease with an extremely variable clinical picture, which makes its diagnosis difficult. No management algorithms for patients with POS complicate their treatment. The paper gives the authors’ data on the long-term results of using metformin as both monotherapy and combination therapy.
Keywords
Full Text
About the authors
E. Sheremetyeva
Endocrinology Research Center
Email: endogin@mail.ru
Moscow
E. Andreeva
Endocrinology Research CenterProfessor, MD Moscow
I. Dedov
Endocrinology Research CenterProfessor, Academician of the Russian Academy of Medical Sciences and the Russian Academy of Sciences Moscow
References
- Курмачева Н.А., Саяпин С.В., Киреев Р.Ф. и др. Опыт применения Сиофора (метформина) у женщин с абдоминальным ожирением и бесплодием // Проблемы репродукции. - 2003; 9 (2): 51-4.
- Мамедов М.Н., Метельская В.В., Перова Н.В. Метаболический синдром: пути реализации атеротромбогенного потенциала // Кардиология. - 2000; 2: 83-9.
- Шостак Н.А., Аничков Д.А. К вопросу о диагностических критериях метаболического синдрома // РМЖ. - 2002; 10 (27, 171): 1255-57.
- Acbay O., Gundogdu S. Can metformin reduce insulin resistance in polycystic ovary syndrome? // Fertil. Steril. - 1996; 65: 946-9.
- Andersen P. et al. Increased insulin sensitivity and fibrinolytic capacity after dietary intervention in obese women with polycystic ovary syndrome // Metabolism. - 1995; 44: 611-7.
- Argaud D., Roth H., Wiemsperger N. et al. Metformin decreases gluconeogenesis by enhancing the pyruvate kinase flux in isolated rat hepatocytes // Eur. J. Biochem. - 1993; 213: 1341-8.
- Barbieri R., Hornstein M. Hyperinsulinemia and ovarian hyperandrogenism: cause and effect // Endocrinol. Metab. Clin. North. Am. - 1988; I7: 685-97.
- Barbieri R., Makris A., Ryan K. Insulin stimulates androgen accumulation in incubation of human ovarian stroma and theca // Obstet. Gynecol. - 1984; 64: 73-80.
- Caro F. Insulin resistance in obese and nonobese man // Clin. Endocrinol. Metab. - 1991; 73: 691-5.
- Timmins P., Donahue S., Meeker J. et al. Steadystate pharmacokinetics of a novel extended-release metformin formulation // Clin. Pharmacokinet. - 2005; 44: 721-9.
- Markku T., Mauri L., Jari J. et al. Insulin resistance and depression: cross sectional study // BMJ. - 2005; 330 (7481): 17-8.
- Irent M., Austin S., Rich M. et al. Overweight status of adolescent girls with polycystic ovary syndrome: body mass index as mediator of quality of life // Ambul. Рediatr. - 2005; 5: 107-11.
- Rasgon N., Rao R., Hwang S. et al. Depression in women with polycystic ovary syndrome Clinical and biochemical correlates О // Affect. Disord. - 2003; 74: 299-304.
- Egges S., Kirchengast S. The polycystic ovary syndrome - a medical condition but also an important psychosocial problem // Coll. Antropol. - 2001; 25: 673-85.
- Haffner S. Risk constellations in patients with the metabolic syndrome: epidemiology, diagnosis, and the treatment patterns // Am. J. Med. - 2006; 119 (5 Suppl. 1): S3-9.
Supplementary files
